Products
Lomustine was commercially available in the form of capsules (Ceenu). It had been approved in many countries since 1981.
Structure and properties
Lomustine (C9H16ClN3O2, Mr = 233.7 g/mol) is a yellow crystalline powder that is practically insoluble in water. It is an N-nitrosourea.
Effects
Lomustine (ATC L01AD02) is alkylating and cytostatic.
Indications
- Brain tumors
- Hodgkin’s disease
- Bronchial carcinomas
- Non-Hodgkin’s lymphoma
- Malignant melanoma
- Renal carcinoma
- Gastrointestinal tumors